MicroPort CardioFlow Medtech Corporation (HKG:2160)

Market Cap	4.97B +182.0%
Revenue (ttm)	402.73M -4.0%
Net Income	5.32M
EPS	0.00
Shares Out	6.37B
PE Ratio	934.02
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,940,000
Average Volume	11,191,262
Open	0.7800
Previous Close	0.7800
Day's Range	0.7700 - 0.7900
52-Week Range	0.7000 - 1.6900
Beta	0.30
RSI	26.02
Earnings Date	Mar 27, 2026

About HKG:2160

MicroPort CardioFlow Medtech Corporation, a medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People’s Republic of China and internationally. The company engages in research and development, manufacture, and sale of medical devices in the field of left atrial appendage, and treating valvular heart diseases, as well as properties management. It’s product portfolio includes transcatheter aortic valves, left atrial appendage closure, tran...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Employees: 417
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2160

Financial Performance

In 2024, HKG:2160's revenue was 361.57 million, an increase of 7.54% compared to the previous year's 336.22 million. Losses were -49.45 million, -89.51% less than in 2023.

Financial numbers in CNY